At Two Scenarios, we conduct global pricing consultancy projects using our global pricing model, IRENE. If you choose us to conduct your pricing analyses, they will be executed by pricing experts with a unique understanding of how pharmaceutical products are priced and regulated worldwide. We will present the results clearly and in an easy-to-understand manner.
We can assist you in planning the next pharmaceutical launch with a launch sequence optimisation analysis. In this analysis, we identify the most profitable launch sequence based on global turnover and highlight relevant characteristics, including:
+ The optimal order to launch the product in different countries, considering local prices, expected sales volumes, discounts, approval processes, and legislations.
+ Consequences for global turnover resulting from changes in prices, launch dates, exchange rates, and discounts in key markets.
+ Consequences to the current launch sequence if a new indication is approved.
We always maintain a close dialogue with our customers during the preparation of a consultancy project to ensure alignment. Before finalizing the report, we present the findings and incorporate your input.
If you are interested to hear more about Two Scenarios and our consultancy services we are always happy to have an informal chat.
Flaesketorvet 68
DK-1620 Vesterbro
